Pfizer Inc. (1PFE)
MTA
24.64
-0.59 (-2.32%)
Closed
Oct 2, 2026
Day's Range
24.6025.08
52 wk Range
20.4525.50
Financial Statements - 1PFE - Pfizer Inc.
Revenue
62.57B▲ 16.1%
Net Income
7.81B▲ 14.4%Net Margin 12.5%
EBITDA
25.74B▲ 34.4%
Free Cash Flow
9.07B▲ 8.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 62.57B | 53.90B | 59.55B | 101.17B | 81.28B | 41.65B |
| Cost of Goods | 16.06B | 15.12B | 24.95B | 34.34B | 30.82B | 8.48B |
| Gross Profit | 46.51B | 38.78B | 34.59B | 66.83B | 50.46B | 33.16B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 17.40B | 12.56B | 4.41B | 38.11B | 23.70B | 8.82B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -7.81B | -3.60B | -2.77B | -2.40B | 1.76B | -415M |
| Pre Tax Income | 7.52B | 6.79B | 1.05B | 34.72B | 24.31B | 7.03B |
| Income Tax | -266M | -23.72M | -1.11B | 3.32B | 1.85B | 370M |
| Net Income | 7.81B | 6.82B | 2.15B | 31.40B | 22.02B | 9.19B |
| EPS Basic | 1.37 | 1.42 | 0.38 | 5.59 | 3.92 | 1.73 |
| EPS Diluted | 1.36 | 1.41 | 0.37 | 5.47 | 3.85 | 1.71 |
| Basic Shares Outstanding | 5.68B | 4.79B | 5.87B | 5.83B | 5.82B | 5.78B |
| Diluted Shares Outstanding | 5.68B | 4.79B | 5.87B | 5.83B | 5.82B | 5.78B |
| Ebit | 10.19B | 9.41B | 3.26B | 35.96B | 25.60B | 8.48B |
| Ebitda | 25.74B | 19.14B | 14.44B | 45.09B | 33.59B | 14.92B |
| Net Income Continuous Operations | 7.78B | 6.82B | 2.17B | 31.40B | 22.45B | 7.02B |
| Minority Interests | -41M | -31M | -39M | -35M | -45M | -36M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
